Drug Shortage Legislation Possible As US FDA Seeks New Powers To Prevent Problems
Executive Summary
Commissioner Gottlieb proposes new authorities that could require manufacturers of certain drugs to establish risk mitigation plans to avert potential drug shortages.
You may also be interested in...
Medical Countermeasures: Long-Term Funding Could Spur More Development Work
Chimerix CEO tells Congress allocating Project Bioshield a multi-year funding stream would provide more long-term certainty for countermeasure sponsors.
As Saline Shortages Persist, Providers Pin Hopes On Feds Demanding Backup Manufacturing Capacity
As market forces, seasonal flu and extreme weather cause US shortages of intravenous saline solutions to persist, providers writing in NEJM are heartened by idea that federal Homeland Security Department could step in to require manufacturing redundancies. Will industry solve the problem before it becomes a matter of national security?
FDA Focusing On Drug Shortage Risks From Puerto Rico Hurricane
FDA has identified more than 40 high-priority drug products from at least five companies and is offering assistance to resume operations, including 'coordinating transport of certain critical drugs out of Puerto Rico.'